| Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT (NCT05183776) | Radboud University Medical Center | 2022-07-12 |
| Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment (NCT05677724) | Fubing Wang | 2022-07-01 |
| Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers (NCT05353894) | Genoscience Pharma | 2022-05-02 |
| Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer (NCT05292443) | Geneplus-Beijing Co. Ltd. | 2021-12-20 |
| Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer (NCT04806464) | CNBG-Virogin Biotech (Shanghai) Ltd. | 2021-03-16 |
| Preoperative Physical Activity Intervention in Patients Before Planned Liver Resection for Cancer (APACHE) (NCT03518632) | Célia Turco | 2018-03-27 |
| Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium (NCT03215355) | Slawa Cwajna | 2017-08-01 |
| Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma (NCT03178929) | Beijing Insight Science & Technology Co. Ltd. | 2017-07-01 |
| Chinese Liver Cancer Clinical Survey (NCT03161925) | Beijing Insight Science & Technology Co. Ltd. | 2016-11-28 |
| Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT) (NCT02722395) | Duke University | 2016-08-01 |
| The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer (NCT02327819) | Tel-Aviv Sourasky Medical Center | 2015-01-01 |
| A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection (NCT01829971) | Mirna Therapeutics, Inc. | 2013-04-01 |
| Primary Liver Cancer Cohort of South China (NCT03297255) | Huilian Zhu | 2013-01-01 |
| Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC) (NCT01116804) | University Hospital, Ghent | 2010-06-16 |
| Clinical Characteristics of Primary Liver Cancer (NCT06325267) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2010-01-01 |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms (NCT01640522) | University of Pittsburgh | 2008-01-01 |
| Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma (NCT00568308) | Progen Pharmaceuticals | 2007-12-01 |
| Evaluation of Preoperative Investigations in Patients With Liver Cancer (NCT00408122) | Odense University Hospital | 2007-01-01 |
| Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation (NCT00261378) | Boston Scientific Corporation | 2005-11-01 |
| TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma (NCT00906984) | University of California, Irvine | |